Pharmosa Biopharm (ROCO:6875) EV-to-EBITDA : 168.63 (As of Jun. 01, 2024)

Pharmosa Biopharm EV-to-EBITDA Chart

Pharmosa Biopharm Quarterly Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-EBITDA	Get a 7-Day Free Trial									-56.61	-56.85	124.68	273.84	178.27

Competitive Comparison of Pharmosa Biopharm's EV-to-EBITDA

For the Biotechnology subindustry, Pharmosa Biopharm's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharmosa Biopharm's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharmosa Biopharm's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Pharmosa Biopharm's EV-to-EBITDA falls into.

Pharmosa Biopharm EV-to-EBITDA Calculation

Pharmosa Biopharm's EV-to-EBITDA for today is calculated as:

Pharmosa Biopharm's current Enterprise Value is NT$8,124.4 Mil.
Pharmosa Biopharm's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$48.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmosa Biopharm  (ROCO:6875) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Pharmosa Biopharm's PE Ratio for today is calculated as:

Pharmosa Biopharm's share price for today is NT$76.40.
Pharmosa Biopharm's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0.176.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Pharmosa Biopharm EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Pharmosa Biopharm's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmosa Biopharm (ROCO:6875) Business Description